ENVALITH
株式会社ハーバー研究所 logo

HABA LABORATORIES,INC.

4925Standard MarketChemicals

株式会社ハーバー研究所 logo
HABA LABORATORIES,INC.4925
Reference Indicators

Market Cap

68¥100M

P/E (Forecast)

13.9x

P/B

0.7x

Dividend Yield (Forecast)

2.31%

ROE

8.2%

EV/EBITDA

2.4x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
12,90812,03812,32412,06112,141
Cost of Sales
4,1143,8693,9203,9694,054
Gross Profit
8,7948,1688,4038,0928,086
SG&A Expenses
9,1118,7788,5917,5037,359
Operating Income
-316-609-187589727
Non-operating Income
323463613
Non-operating Expenses
87101732
Ordinary Income
-292-582-191608708
Extraordinary Income
11037527142
Extraordinary Losses
8431,65600
Pre-tax Income
-266-548-1,843635850
Income Taxes
21592755989
Net Income
-269-707-2,118576760
EBITDA
391-49331748913
Gross Margin
68.1%67.9%68.2%67.1%66.6%
Operating Margin
-2.5%-5.1%-1.5%4.9%6.0%
ROA
-1.7%-4.8%-17.0%4.7%6.1%
ROE
-2.3%-6.3%-22.0%6.6%8.2%